Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Protalix Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.76
04.04.22
€0.000
04.04.23
-33.28%
18.04.22

EBIT decline > 20% expected
Revenue decline > 20% expected
Very low/no dividend yield expected
Sustainability is not important
Marianka 
04.04.22 50%
sell
Protalix Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.76
04.04.22
€0.000
04.04.23
-35.27%
02.06.22

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline > 20% expected
overvalued
dimontalban 
04.04.22 40%
buy
Curis Inc.

Start price
Target price
Perf. (%)
€1.39
04.04.22
-
04.04.23
-17.86%
16.04.22

me8 
04.04.22 0%
buy
Protalix Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.42
04.04.22
-
04.04.23
-17.54%
16.04.22

me8 
04.04.22 0%
buy
Bayer AG

Start price
Target price
Perf. (%)
€64.79
04.04.22
-
04.04.23
-13.40%
06.07.22

CerealKiller 
04.04.22 50%
buy
Protalix Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.46
04.04.22
-
04.04.23
36.94%
05.04.23

zoeNEWYORK 
04.04.22 0%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€54.15
04.04.22
€65.00
04.04.23
5.47%
16.04.22

gerihouse_ctm 
04.04.22 70%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€46.84
04.04.22
€55.00
04.04.23
2.48%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
04.04.22 80%
buy
Bayer AG

Start price
Target price
Perf. (%)
€64.90
04.04.22
-
04.05.22
-4.38%
05.05.22

Sukram 
04.04.22 50%
buy
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€1.69
04.04.22
€1.60
04.04.23
-50.59%
05.04.23

krebskrebs 
04.04.22 50%
buy
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€3.31
03.04.22
-
03.04.23
-11.44%
18.04.22

quelbe60 
03.04.22 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€6.77
03.04.22
-
03.04.23
-15.85%
18.04.22

quelbe60 
03.04.22 50%
buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€52.04
03.04.22
€69.00
03.04.23
31.30%
24.08.22

RudolfL 
03.04.22 50%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€19.07
03.04.22
-
03.04.23
-53.28%
04.04.23

FXX 
03.04.22 50%
buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€8.44
03.04.22
-
03.05.22
-3.79%
04.05.22

heckma01 
03.04.22 50%
sell
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.28
03.04.22
-
03.04.23
-98.20%
04.04.23

Probably not worthwhile Investment
Lokrim 
03.04.22 20%
buy
Cellectis SA ADR

Start price
Target price
Perf. (%)
€4.20
03.04.22
-
03.04.23
-58.10%
04.04.23

Could be worthwhile Investment >10% per year
Lokrim 
03.04.22 20%
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€40.88
03.04.22
-
03.04.23
39.43%
04.04.23

Could be worthwhile Investment >10% per year
Lokrim 
03.04.22 20%
buy
Akebia Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.62
03.04.22
-
03.04.23
-37.48%
12.05.22

tinelchen 
03.04.22 0%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€240.95
02.04.22
€330.00
02.04.23
20.67%
03.04.23

skatcup 
02.04.22 80%
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€76.43
02.04.22
€90.00
02.04.23
67.74%
03.04.23

skatcup 
02.04.22 50%
buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€101.00
02.04.22
€150.00
02.04.23
45.52%
03.04.23

skatcup 
02.04.22 50%
buy
Incyte Corp.

Start price
Target price
Perf. (%)
€72.11
02.04.22
€90.00
02.04.23
-7.06%
03.04.23

skatcup 
02.04.22 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€28.19
02.04.22
€25.00
02.04.23
-32.58%
03.04.23

skatcup 
02.04.22 90%
buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€184.00
02.04.22
€200.00
02.04.23
-15.22%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
skatcup 
02.04.22 50%